Table 1.
Demographic and Risk Factor Data
| Patients for Zoster and Stroke Analyses |
Patients for the Zoster and MI Analyses |
||||||||
|---|---|---|---|---|---|---|---|---|---|
| N (%) with zoster 4478 Total |
N (%) without zoster/ 16800 Total |
Chi- square P-value |
N (%) with zoster 4454 Total |
N (%) without zoster 16740 Total |
Chi- square P-value |
||||
| Sex = female | 2782 (62.1) | 10513 (62.6) | .59 | 2826 (63.4) | 10831 (64.7) | .12 | |||
| Age mean (range) | 68.5 (50,106) | 67.8 (49,106) | < .001 | 68.6 (50,106) | 68.1 (49,106) | .01 | |||
| Age 50–64 | 1964 (43.9) | 7717 (45.9) | .01 | 1944 (43.6) | 7604 (45.4) | .04 | |||
| Age 65–79 | 1662 (37.1) | 6163 (36.7) | .61 | 1647 (37.0) | 6053 (36.2) | .32 | |||
| Age 80+ | 852 (19) | 2920 (17.4) | .01 | 863 (19.4) | 3083 (18.4) | .02 | |||
| Morbidities | 2065 (46.4) | 6526 (39.0) | < .001 | ||||||
| Hypertension | 2068 (46.2) | 6473 (38.5) | < .001 | 2065 (46.4) | 6526 (39.0) | < .001 | |||
| CAD | 861 (19.2) | 2380 (14.2) | < .001 | 668 (15.0) | 1818 (10.9) | < .001 | |||
| MI before index | 312 (7.0) | 900 (5.4) | < .001 | NA | NA | NA | |||
| Arrhythmias | 953 (21.3) | 2589 (15.4) | < .001 | 917 (20.6) | 2543 (15.2) | < .001 | |||
| Dyslipidemia | 1941 (43.3) | 5955 (35.4) | < .001 | 1873 (42.1) | 5808 (34.7) | < .001 | |||
| Depression | 850 (19) | 2640 (15.7) | < .001 | 862 (19.4) | 2718 (16.2) | < .001 | |||
| Diabetes | 873 (19.5) | 2769 (16.5) | < .001 | 866 (19.4) | 2741 (16.4) | < .001 | |||
| Substance abuse | 183 (4.1) | 649 (3.9) | .52 | 188 (4.2) | 621 (3.7) | .12 | |||
| Anxiety | 662 (14.8) | 2020 (12) | < .001 | 663 (14.9) | 2053 (12.3) | < .001 | |||
| Vasculopathy | 118 (2.6) | 316 (1.9) | .002 | 174 (3.9) | 509 (3.0) | < .001 | |||
| Number of events for each analysis (Strokes) | Number of events for each analysis (MI) | 35 (0.8) | 81 (0.5) | .02 | |||||
| within 3 months | 33 (0.7) | 73 (0.4) | .02 | 24 (0.5) | 48 (0.3) | .02 | |||
| in 6 months | 46 (1) | 123 (0.7) | .06 | 35 (0.8) | 81 (0.5) | .02 | |||
| in 1 year | 71 (1.6) | 235 (1.4) | .39 | 61 (1.4) | 155 (0.9) | .01 | |||
| in 3 years | 176 (3.9) | 591 (3.5) | .20 | 154 (3.5) | 450 (2.7) | .01 | |||
| ever | 562 (12.6) | 1844 (11) | .003 | 443 (9.9) | 1430 (8.5) | < .001 | |||
| Follow-up Period | 1272 (28.6) | 4637 (27.7) | .26 | ||||||
| 90 daus | 4425 (98.8) | 16716 (99.5) | .03 | 4405 (98.9) | 16673 (99.6) | .03 | |||
| 3 years | 4151 (92.7) | 15758 (93.8) | .06 | 4102 (92.1) | 15652 (93.5) | .05 | |||
| > 5 years | 2508 (56) | 9155 (54.5) | .07 | 2481 (55.7) | 9034 (54.0) | .04 | |||
| > 10 years | 1281 (28.6) | 4659 (27.7) | .25 | 1272 (28.6) | 4637 (27.7) | .26 | |||
| > 15 years | 506 (11.3) | 1904 (11.3) | .97 | 519 (11.7) | 1915 (11.4) | .71 | |||